Ruben, Eglesiria D.
HRN: 22-07-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/25/2022
10/31/2022
IV
1.5g
Q8
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes